• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合组学数据与蛋白质相互作用网络以对癌症中的驱动基因进行优先级排序。

Integrating omics data and protein interaction networks to prioritize driver genes in cancer.

作者信息

Zhang Tiejun, Zhang Di

机构信息

GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, Guangdong 511436, China.

School of Computer Science and Technology, Anhui University, Hefei, Anhui 230601, China.

出版信息

Oncotarget. 2017 Jul 22;8(35):58050-58060. doi: 10.18632/oncotarget.19481. eCollection 2017 Aug 29.

DOI:10.18632/oncotarget.19481
PMID:28938536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5601632/
Abstract

Although numerous approaches have been proposed to discern driver from passenger, identification of driver genes remains a critical challenge in the cancer genomics field. Driver genes with low mutated frequency tend to be filtered in cancer research. In addition, the accumulation of different omics data necessitates the development of algorithmic frameworks for nominating putative driver genes. In this study, we presented a novel framework to identify driver genes through integrating multi-omics data such as somatic mutation, gene expression, and copy number alterations. We developed a computational approach to detect potential driver genes by virtue of their effect on their neighbors in network. Application to three datasets (head and neck squamous cell carcinoma (HNSC), thyroid carcinoma (THCA) and kidney renal clear cell carcinoma (KIRC)) from The Cancer Genome Atlas (TCGA), by comparing the Precision, Recall and F1 score, our method outperformed DriverNet and MUFFINN in all three datasets. In addition, our method was less affected by protein length compared with DriverNet. Lastly, our method not only identified the known cancer genes but also detected the potential rare drivers ( in THCA, , and in KIRC, and in HNSC).

摘要

尽管已经提出了许多方法来区分驱动基因和乘客基因,但在癌症基因组学领域,识别驱动基因仍然是一项关键挑战。突变频率低的驱动基因在癌症研究中往往会被过滤掉。此外,不同组学数据的积累需要开发用于提名潜在驱动基因的算法框架。在本研究中,我们提出了一个通过整合多组学数据(如体细胞突变、基因表达和拷贝数改变)来识别驱动基因的新框架。我们开发了一种计算方法,凭借其对网络中邻居的影响来检测潜在的驱动基因。将其应用于来自癌症基因组图谱(TCGA)的三个数据集(头颈部鳞状细胞癌(HNSC)、甲状腺癌(THCA)和肾透明细胞癌(KIRC)),通过比较精确率、召回率和F1分数,我们的方法在所有三个数据集中均优于DriverNet和MUFFINN。此外,与DriverNet相比,我们的方法受蛋白质长度的影响较小。最后,我们的方法不仅识别出了已知的癌症基因,还检测到了潜在的罕见驱动基因(在THCA中为 ,在KIRC中为 和 ,在HNSC中为 和 )。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f679/5601632/eb20239ce4ea/oncotarget-08-58050-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f679/5601632/910508cfde07/oncotarget-08-58050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f679/5601632/741d2f02a9ce/oncotarget-08-58050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f679/5601632/ee4ac6cf1333/oncotarget-08-58050-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f679/5601632/0607f747bdc4/oncotarget-08-58050-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f679/5601632/eb20239ce4ea/oncotarget-08-58050-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f679/5601632/910508cfde07/oncotarget-08-58050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f679/5601632/741d2f02a9ce/oncotarget-08-58050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f679/5601632/ee4ac6cf1333/oncotarget-08-58050-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f679/5601632/0607f747bdc4/oncotarget-08-58050-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f679/5601632/eb20239ce4ea/oncotarget-08-58050-g005.jpg

相似文献

1
Integrating omics data and protein interaction networks to prioritize driver genes in cancer.整合组学数据与蛋白质相互作用网络以对癌症中的驱动基因进行优先级排序。
Oncotarget. 2017 Jul 22;8(35):58050-58060. doi: 10.18632/oncotarget.19481. eCollection 2017 Aug 29.
2
LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network.LNDriver:基于基因-基因相互作用网络整合突变和表达数据来识别驱动基因。
BMC Bioinformatics. 2016 Dec 23;17(Suppl 17):467. doi: 10.1186/s12859-016-1332-y.
3
Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.鉴定多种癌症类型中的驱动拷贝数改变,并将其应用于药物重定位。
Mol Oncol. 2017 Oct;11(10):1459-1474. doi: 10.1002/1878-0261.12112. Epub 2017 Aug 3.
4
Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.在非参数贝叶斯框架下通过综合基因组学方法发现癌症驱动基因。
Bioinformatics. 2017 Feb 15;33(4):483-490. doi: 10.1093/bioinformatics/btw662.
5
A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.基于分子数据整合的潜在癌症驱动基因鉴定新方法
Biochem Genet. 2020 Feb;58(1):16-39. doi: 10.1007/s10528-019-09924-2. Epub 2019 May 21.
6
Sparse overlapping group lasso for integrative multi-omics analysis.用于综合多组学分析的稀疏重叠组套索法
J Comput Biol. 2015 Feb;22(2):73-84. doi: 10.1089/cmb.2014.0197. Epub 2015 Jan 28.
7
Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis.通过网络富集分析区分个体癌症基因组中的驱动突变和乘客突变。
BMC Bioinformatics. 2014 Sep 19;15(1):308. doi: 10.1186/1471-2105-15-308.
8
DriverSubNet: A Novel Algorithm for Identifying Cancer Driver Genes by Subnetwork Enrichment Analysis.驱动子网:一种通过子网富集分析识别癌症驱动基因的新算法。
Front Genet. 2021 Feb 19;11:607798. doi: 10.3389/fgene.2020.607798. eCollection 2020.
9
Interaction-Based Feature Selection for Uncovering Cancer Driver Genes Through Copy Number-Driven Expression Level.基于相互作用的特征选择,通过拷贝数驱动的表达水平来揭示癌症驱动基因。
J Comput Biol. 2017 Feb;24(2):138-152. doi: 10.1089/cmb.2016.0140. Epub 2016 Oct 19.
10
DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer.驱动网络:揭示体细胞驱动突变对癌症转录网络的影响。
Genome Biol. 2012 Dec 22;13(12):R124. doi: 10.1186/gb-2012-13-12-r124.

引用本文的文献

1
From Data to Cure: A Comprehensive Exploration of Multi-omics Data Analysis for Targeted Therapies.从数据到治愈:靶向治疗多组学数据分析的全面探索
Mol Biotechnol. 2025 Apr;67(4):1269-1289. doi: 10.1007/s12033-024-01133-6. Epub 2024 Apr 2.
2
Regulation of microRNA expression by the adaptor protein GRB2.衔接蛋白 GRB2 对 microRNA 表达的调控。
Sci Rep. 2023 Jun 16;13(1):9784. doi: 10.1038/s41598-023-36996-3.
3
A full-proteome, interaction-specific characterization of mutational hotspots across human cancers.全蛋白质组水平上对人类癌症中突变热点的交互特异性特征分析。

本文引用的文献

1
p38 MAPK mediates epithelial-mesenchymal transition by regulating p38IP and Snail in head and neck squamous cell carcinoma.p38丝裂原活化蛋白激酶通过调节头颈部鳞状细胞癌中的p38相互作用蛋白(p38IP)和蜗牛蛋白(Snail)介导上皮-间质转化。
Oral Oncol. 2016 Sep;60:81-9. doi: 10.1016/j.oraloncology.2016.06.010. Epub 2016 Jul 15.
2
MUFFINN: cancer gene discovery via network analysis of somatic mutation data.MUFFINN:通过体细胞突变数据的网络分析发现癌症基因
Genome Biol. 2016 Jun 23;17(1):129. doi: 10.1186/s13059-016-0989-x.
3
Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis.
Genome Res. 2022 Jan;32(1):135-149. doi: 10.1101/gr.275437.121. Epub 2021 Dec 28.
4
Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles.从突变和基因表达谱的泛癌分析中发现新的驱动突变。
PLoS One. 2020 Nov 24;15(11):e0242780. doi: 10.1371/journal.pone.0242780. eCollection 2020.
5
Mitochondria under the spotlight: On the implications of mitochondrial dysfunction and its connectivity to neuropsychiatric disorders.聚焦线粒体:线粒体功能障碍的影响及其与神经精神疾病的关联
Comput Struct Biotechnol J. 2020 Sep 14;18:2535-2546. doi: 10.1016/j.csbj.2020.09.008. eCollection 2020.
6
Identification of osteosarcoma driver genes using a network method.使用网络方法鉴定骨肉瘤驱动基因。
Oncol Lett. 2020 Feb;19(2):1215-1222. doi: 10.3892/ol.2019.11212. Epub 2019 Dec 12.
7
MECoRank: cancer driver genes discovery simultaneously evaluating the impact of SNVs and differential expression on transcriptional networks.MECoRank:同时评估 SNVs 和差异表达对转录网络影响的癌症驱动基因发现。
BMC Med Genomics. 2019 Dec 30;12(Suppl 7):140. doi: 10.1186/s12920-019-0582-8.
8
Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis.多网络和通路的整合分析鉴定了泛癌分析中的癌症驱动基因。
BMC Genomics. 2018 Jan 6;19(1):25. doi: 10.1186/s12864-017-4423-x.
甲状腺癌的基因组分析揭示了甲状腺球蛋白在转移中的作用。
Am J Hum Genet. 2016 Jun 2;98(6):1170-1180. doi: 10.1016/j.ajhg.2016.04.014. Epub 2016 May 26.
4
Identification of Novel Oncogenic Mutations in Thyroid Cancer.鉴定甲状腺癌中的新型致癌突变。
J Am Coll Surg. 2016 Jun;222(6):1036-1043.e2. doi: 10.1016/j.jamcollsurg.2015.12.047. Epub 2016 Jan 14.
5
Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinoma.Src和STAT3抑制剂协同作用以促进肾细胞癌的肿瘤抑制。
Oncotarget. 2015 Dec 29;6(42):44675-87. doi: 10.18632/oncotarget.5971.
6
Expression and clinical significance of tyrosine phosphatase SHP2 in thyroid carcinoma.酪氨酸磷酸酶SHP2在甲状腺癌中的表达及临床意义
Oncol Lett. 2015 Sep;10(3):1507-1512. doi: 10.3892/ol.2015.3479. Epub 2015 Jul 10.
7
Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.癌症基因组中用于优先确定驱动突变和显著突变基因的计算方法进展。
Brief Bioinform. 2016 Jul;17(4):642-56. doi: 10.1093/bib/bbv068. Epub 2015 Aug 24.
8
MEMCover: integrated analysis of mutual exclusivity and functional network reveals dysregulated pathways across multiple cancer types.MEMCover:互斥性与功能网络的综合分析揭示多种癌症类型中的失调通路
Bioinformatics. 2015 Jun 15;31(12):i284-92. doi: 10.1093/bioinformatics/btv247.
9
Integrative network-based approach identifies key genetic elements in breast invasive carcinoma.基于整合网络的方法识别乳腺浸润性癌中的关键遗传元件。
BMC Genomics. 2015;16 Suppl 5(Suppl 5):S2. doi: 10.1186/1471-2164-16-S5-S2. Epub 2015 May 26.
10
Evaluation and integration of cancer gene classifiers: identification and ranking of plausible drivers.癌症基因分类器的评估与整合:合理驱动因素的识别与排序
Sci Rep. 2015 May 11;5:10204. doi: 10.1038/srep10204.